WEX Q2 2020 Earnings Report
Key Takeaways
WEX Inc. reported a 21% decrease in total revenue to $347.1 million compared to Q2 2019, impacted by COVID-19. Net income attributable to shareholders increased to $72.7 million, or $1.66 per diluted share, while adjusted net income was $53.0 million, or $1.21 per diluted share.
Experienced recovery in spend volume trends across all segments during the quarter.
U.S. Health business remained strong with year-over-year top-line growth.
Secured a $400 million investment from Warburg Pincus and amended credit agreement.
Implemented cost containment measures expected to save $60-$65 million for the year.
WEX
WEX
WEX Revenue by Segment
Forward Guidance
WEX withdrew previously-issued full fiscal year 2020 financial guidance due to the continued uncertainty related to COVID-19 and is not providing any further financial guidance at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income